Skip to main content
. 2003 Apr 22;2003(2):CD000218. doi: 10.1002/14651858.CD000218
Methods Consecutive women allocated in a balanced randomisation schedule.
No mention of blind outcome assessment.
Participants 100 women with vaginal discharge in Poona, India were included.
Most partners were treated.
Those receiving antitrichomonal treatment in the past 4 weeks were ineligible.
Interventions Metronidazole 2 g (5 x 400 mg tabs) by mouth single dose versus tinidazole 2 g (4 x 500 mg tabs) by mouth single dose.
Outcomes Parasitological and clinical cure. Side effects.
Notes Diagnosis by wetmount.
Follow up on days 4, 8, and 12.
No exclusions or loss to follow up reported.